Treventis

Small molecule therapeutics targeting misfolded proteins in CNS diseases

placeDover, Delaware, United States calendar_todayFounded 2008 groups15 employees language treventis.com

Innovation

10 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport, Physics & computing; filing pace slowing. Cited 205 times.

YearFilings
20123
20133
20145
20155
20165
20172
20182
20194
20202
20211
20222
20232

Social engagement

Social engagement: 1.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Wellcome Trust.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Other / undisclosed250%

Recent activity

15 Jun 2026
Event
BIO2026
Coming soon